prednisolone has been researched along with Eaton-Lambert Myasthenic Syndrome in 7 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rehman, HU | 1 |
| Verschuuren, JJ | 1 |
| Wirtz, PW | 1 |
| Titulaer, MJ | 1 |
| Willems, LN | 1 |
| van Gerven, J | 1 |
| Newsom-Davis, J | 2 |
| Takata, T | 1 |
| Koide, S | 1 |
| Ogata, K | 1 |
| Motomura, M | 2 |
| Yoshimura, T | 1 |
| Hanajima, R | 1 |
| Sakurai, M | 1 |
| Kanazawa, I | 1 |
| Seneviratne, U | 1 |
| de Silva, R | 1 |
| Ishikawa, S | 1 |
| Takei, Y | 1 |
| Tokunaga, S | 1 |
| Nakao, Y | 1 |
| Hanyu, N | 1 |
| Maddison, P | 1 |
| Lang, B | 1 |
| Mills, K | 1 |
2 reviews available for prednisolone and Eaton-Lambert Myasthenic Syndrome
| Article | Year |
|---|---|
Available treatment options for the management of Lambert-Eaton myasthenic syndrome.
Topics: 4-Aminopyridine; Antineoplastic Agents; Carcinoma, Small Cell; Cholinesterase Inhibitors; Cisplatin; | 2006 |
Lambert-Eaton myasthenic syndrome.
Topics: 4-Aminopyridine; Amifampridine; Anti-Inflammatory Agents; Autoantibodies; Calcium Channels; Carcinom | 1999 |
5 other studies available for prednisolone and Eaton-Lambert Myasthenic Syndrome
| Article | Year |
|---|---|
A 90 year old man with difficulty swallowing and proximal muscle weakness.
Topics: Aged, 80 and over; Cholinesterase Inhibitors; Deglutition Disorders; Diagnosis, Differential; Fatal | 2012 |
A treatment algorithm for Lambert-Eaton myasthenic syndrome.
Topics: 4-Aminopyridine; Algorithms; Amifampridine; Azathioprine; Carcinoma, Small Cell; Clinical Protocols; | 1998 |
Lambert-Eaton myasthenic syndrome associated with idiopathic thrombocytopenic purpura and diffuse panbronchiolitis: long-term remission after a course of intravenous immunoglobulin combined with low-dose prednisolone.
Topics: Anti-Inflammatory Agents; Bronchiolitis; Drug Therapy, Combination; Female; Humans; Immunoglobulins, | 1999 |
[Response to immunoadsorption and steroid therapies in a patient with carcinomatous Lambert-Eaton myasthenia syndrome accompanied by disturbed consciousness].
Topics: Aged; Calcium Channels, N-Type; Carcinoma, Small Cell; Consciousness Disorders; Humans; Immunosorben | 2000 |
Long term outcome in Lambert-Eaton myasthenic syndrome without lung cancer.
Topics: Adolescent; Adult; Aged; Carcinoma, Small Cell; Child; Electromyography; Humans; Lambert-Eaton Myast | 2001 |